Methods of treating or preventing inflammation and hypersensitivity with oxidative reductive potential water solution

A method of preventing or treating a Type I hypersensitivity disorder in a patient, the method consisting of administering to the patient a therapeutically effective amount of an oxidative reductive potential water solution, wherein the solution is stable for at least two months and the solution has a pH of from about 6.4 to about 7.8, wherein the oxidative reductive potential water solution comprises a mixture of cathode water and anode water, wherein the oxidative reductive potential water solution comprises free chlorine species at a level of about 10 ppm to about 400 ppm, wherein the free chlorine species is selected from the group consisting of hypochlorous acid, hypochlorite ions, sodium hypochlorite, chlorite ions, dissolved chlorine gas, and mixtures thereof, wherein the oxidative reductive potential water solution inhibits mast cell degranulation, thereby treating the Type I hypersensitivity disorder.